AgeneBio Appoints Industry Leaders Patrick LePore as Chairman of the Board and Jerry McLaughlin as President and Chief Executive Officer
BALTIMORE, MARYLAND—AgeneBio, Inc., a clinical-stage pharmaceutical company developing medicines to restore and preserve patients’ cognitive function for a range of debilitating neurodegenerative diseases, today announced the appointment of Patrick LePore as chairman of the board and Jerry McLaughlin as president…
